Compare
Balchem Corp vs Innospec Inc. vs FMC Corp vs Huntsman Corp
| Latest fiscal year | Balchem Corp BCPC | Innospec Inc. IOSP | FMC Corp FMC | Huntsman Corp HUN |
|---|---|---|---|---|
| Year ended | 2025-12-31 | 2025-12-31 | 2025-12-31 | 2025-12-31 |
| Revenue | $1.04B | $1.78B | $3.47B | $5.68B |
| Revenue growth (YoY) | +8.8% | -3.7% | -18.3% | -5.8% |
| Gross margin | 35.7% | 27.7% | 37.0% | 13.2% |
| Operating margin | 20.2% | 7.3% | -47.0% | -2.3% |
| Net margin | 14.9% | 6.6% | -64.6% | -5.0% |
| Net income | $154.84M | $116.60M | -$2.24B | -$284.00M |
| EPS (Diluted) | $4.75 | $4.67 | -$17.88 | -$1.65 |
| Operating cash flow | $216.56M | $138.30M | -$6.20M | $289.00M |
| Free cash flow | n/a | n/a | -$102.50M | $116.00M |
| Cash & equivalents | $74.57M | $292.50M | $584.50M | $429.00M |
| Total assets | $1.69B | $1.83B | $9.69B | $7.01B |
| Total liabilities | $428.84M | $499.50M | n/a | $4.06B |
| Shareholders' equity | $1.26B | $1.33B | $2.10B | $2.96B |
| Return on year-end equity | 12.3% | 8.8% | -106.7% | -9.6% |
| Shares outstanding | 32.06M | n/a | n/a | 172.62M |
Revenue, most recent five fiscal years
| Fiscal year | Balchem Corp | Innospec Inc. | FMC Corp | Huntsman Corp |
|---|---|---|---|---|
| Latest | $1.04B Ended 2025-12-31 | $1.78B Ended 2025-12-31 | $3.47B Ended 2025-12-31 | $5.68B Ended 2025-12-31 |
| 1 year earlier | $953.68M Ended 2024-12-31 | $1.85B Ended 2024-12-31 | $4.25B Ended 2024-12-31 | $6.04B Ended 2024-12-31 |
| 2 years earlier | $922.44M Ended 2023-12-31 | $1.95B Ended 2023-12-31 | $4.49B Ended 2023-12-31 | $6.11B Ended 2023-12-31 |
| 3 years earlier | $942.36M Ended 2022-12-31 | $1.96B Ended 2022-12-31 | $5.80B Ended 2022-12-31 | $8.02B Ended 2022-12-31 |
| 4 years earlier | $799.02M Ended 2021-12-31 | $1.48B Ended 2021-12-31 | $5.05B Ended 2021-12-31 | $7.67B Ended 2021-12-31 |